黄金城游戏

January 4, 2016, Haier Bio-Medical, an independent subsidiary in Haier Group focusing on medical research business, completed the business acquisition of cold chain products of LabTech, a British scientific 黄金城游戏 company. It is the first international strategic capital investment since transformation and upgrading of Haier Bio-Medical. The acquisition is intended to enhance the comprehensive global market distribution of Haier Bio-Medical products and to provide key support for its transformation of medical and 黄金城游戏 programs and services.

LabTech, founded in 1993, is a specialty supplier for laboratory and scientific products and consumable products.  It is also a service provider for such 黄金城游戏. As a company operating in the United Kingdom for over 20 years, LabTech has accumulated abundant user resources in the industry and maintains a mature professional team of experienced service personnel and professionals for scientists and researchers.

The acquisition allows an opportunity to combine the two businesses and share resources. User-oriented LabTech in the field of 黄金城游戏s is fully consistent with business areas of Haier, thus boasting core competitiveness of products and programs in the field of low-temperature cold chain, biological sample bank and laboratory 黄金城游戏. While LabTech focuses on clients, combination of the two companies will provide a sound user experience from 黄金城游戏 to application. In addition, Haier Bio-Medical, as a newcomer in the UK market, will be able to make full use of LabTech’s accumulated user resources in the industry to better understand customer needs and to improve user experience and satisfaction, thereby rapidly expanding its UK market share and expanding this business model in Europe, Australia and other markets. In the long run, this process will be an important part for Haier Bio-Medical to have its globalization presence.

In fact, this acquisition is not the first step to globalization for Haier Bio-Medical, which entered the overseas market as early as 2006. 10 years of innovation and dedicated undertaking have established Haier Bio-Medical as one of the world's top six cryogenic cold chain brands. Its cold chain products, represented by ultra-low temperature freezers, have successfully entered the United States, Australia, Europe and other high-end medical research markets and provided services to 黄金城游戏 research around the world. Vaccine refrigerators, created by Haier Bio-Medical, have received PQS certification issued by World Health Organization, and have been the first certificated cold chain products in Asian countries. Haier Bio-Medical also establishes a long-term procurement contract partnership with UNICEF and other organizations. Over 50,000 Haier vaccine refrigerators are now operating to help over ten million women and children to improve their health condition in India, Asia, Africa and Latin America.

Haier’s cold chain products have enjoyed a rapid growth in recent years, especially in the UK market. Haier ultra-low temperature freezers were installed in UK-Biobanks and thoroughly appreciated by the UK customers. They are now found at University of Birmingham, Oxford University, University of Brighton, England Public Health Center and other world-renowned medical research institutions. Haier products have successfully been competing with other international brands in the market place and receiving support from local customers.  This provides a strong basis for Haier Bio-Medical to penetrate into the UK market.

After the successful acquisition of LabTech’s business in cold chain products, Haier Bio-Medical will set up a wholly-owned subsidiary in UK, therefore enhancing its brand penetration and influence in the UK market.  Additionally, the new business entity will assist Haier low-temperature cold chain and laboratory products to serve British customers more quickly and more conveniently. Meanwhile, both sides will jointly explore potential customer needs, introduce advanced technology and create a series of advanced products and solutions in laboratory industry to serve the global market.

Haier Bio-Medical

Haier Bio-Medical, as one of the subsidiaries of Haier Group, is the largest low-temperature cold chain and scientific 黄金城游戏 provider based in China. It began designing and producing China's first -86^oC ultra-low temperature freezer in 2006. Over the course of 5 years, Haier Bio-Medical completed the demonstration project of 100 ultra-low temperature freezers in the China Bone Marrow Bank to share the biggest ULT market in China. In 2009, the company, based on ultra-low temperature freezers, extends product innovation to sample processing, storage, information management and application of BIMS biological bank solutions. The company has built such basic research platforms as National Gene Bank, as well as protein library, pediatrics sample library, serum sample library in China. In 2011, Haier aerospace refrigerators were carried by Shenzhou spacecraft spaceship into the space three times.  The company became the only organization to accomplish this in the global household electrical appliance industry. Haier Bio-Medical was awarded the second prize of 2013 National Science and Technology Progress Award thanks to its technology in "ultra-low temperature freezer", and is the only receiver of National Science and Technology Progress Award in China’s low-temperature refrigeration industry. In the future, Haier, through its user resources in the high-end medical and science research driven by biological bank, will enter such medical and 黄金城游戏s and up- and down-stream industry chains as cryogenic storage, automated storage, genetic testing, diagnosis, cell therapy, research of large data, so as to support the development of China's national medical research industry.

As for detailed information, please visit http://www.haiermedical.com or phone 4006 99 2008